Details for 2021189378

Up to date per 02.04.2026

Actions

Title / Product Name

KONDENSIERTE PENTACYCLISCHE IMIDAZOLDERIVATE ALS MODULATOREN DER TNF-AKTIVITÄT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021189378

EP Publication Number

3939980

E-Number

1591246

Language

PCT Number

Publication Date

19.01.2022 A

26.07.2023 B1

Registration Date

26.07.2023

AT Publication Date

15.08.2023

Application Date

24.04.2018

Registration Number

Priorities

25.04.2017

17168027

IPC

A61P 19/02 20060101AFI20220816BHEP

Maximum Duration of Protection

24.04.2038

Owner

UCB Biopharma SRLAllée de la Recherche 601070 BrusselsBE

SANOFI46 avenue de la Grande Armée75017 ParisFR

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

BROOKINGS, Daniel Christopher Slough, SL1 3WEGB

DE HARO GARCIA, Teresa Slough, SL1 3WEGB

FORICHER, Yann 75008 ParisFR

HORSLEY, Helen Tracey Slough, SL1 3WEGB

HUTCHINGS, Martin Clive Slough, SL1 3WEGB

JOHNSON, James Andrew Slough, SL1 3WEGB

MACCOSS, Malcolm South Carolina, 29455US

XUAN, Mengyang Slough, SL1 3WEGB

ZHU, Zhaoning Slough, SL1 3WEGB

Information about Fees